Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocardium | 5 | 2014 | 529 | 1.540 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 2 | 2 | 2014 | 3 | 0.950 |
Why?
|
| Adenoviridae | 3 | 2012 | 345 | 0.940 |
Why?
|
| Phosphodiesterase Inhibitors | 2 | 2014 | 30 | 0.930 |
Why?
|
| Endothelial Cells | 9 | 2016 | 428 | 0.750 |
Why?
|
| Capillary Permeability | 4 | 2016 | 130 | 0.750 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2 | 2009 | 21 | 0.700 |
Why?
|
| Genetic Vectors | 4 | 2013 | 439 | 0.660 |
Why?
|
| Gene Knockdown Techniques | 6 | 2016 | 236 | 0.640 |
Why?
|
| Triazines | 2 | 2014 | 53 | 0.590 |
Why?
|
| Chylomicrons | 1 | 2016 | 12 | 0.570 |
Why?
|
| Lysophosphatidylcholines | 1 | 2016 | 18 | 0.570 |
Why?
|
| Lymph | 1 | 2016 | 13 | 0.570 |
Why?
|
| Imidazoles | 2 | 2014 | 162 | 0.570 |
Why?
|
| Docosahexaenoic Acids | 1 | 2016 | 31 | 0.550 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2016 | 1219 | 0.540 |
Why?
|
| Dietary Fats | 1 | 2016 | 135 | 0.530 |
Why?
|
| Cyclic GMP | 3 | 2014 | 58 | 0.530 |
Why?
|
| Carbon-13 Magnetic Resonance Spectroscopy | 1 | 2014 | 1 | 0.510 |
Why?
|
| Genetic Therapy | 2 | 2008 | 342 | 0.510 |
Why?
|
| Rats | 8 | 2016 | 3990 | 0.500 |
Why?
|
| Nerve Regeneration | 1 | 2014 | 32 | 0.500 |
Why?
|
| Catenins | 2 | 2011 | 11 | 0.500 |
Why?
|
| Stress, Psychological | 2 | 2014 | 313 | 0.490 |
Why?
|
| Glutamic Acid | 1 | 2014 | 152 | 0.480 |
Why?
|
| Fatty Acids | 1 | 2014 | 130 | 0.480 |
Why?
|
| Connexin 43 | 1 | 2014 | 94 | 0.480 |
Why?
|
| Hippocampus | 2 | 2014 | 442 | 0.470 |
Why?
|
| Cardiomegaly | 2 | 2017 | 111 | 0.470 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2014 | 69 | 0.460 |
Why?
|
| Malate Dehydrogenase | 1 | 2012 | 8 | 0.450 |
Why?
|
| Pharmacological Phenomena | 1 | 2012 | 1 | 0.450 |
Why?
|
| Pharmacology, Clinical | 1 | 2012 | 9 | 0.440 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 1 | 2012 | 15 | 0.440 |
Why?
|
| Cognition | 2 | 2014 | 570 | 0.440 |
Why?
|
| Artifacts | 1 | 2014 | 244 | 0.440 |
Why?
|
| Pharmaceutical Preparations | 1 | 2014 | 92 | 0.440 |
Why?
|
| Corticosterone | 1 | 2012 | 35 | 0.430 |
Why?
|
| Cognition Disorders | 1 | 2014 | 236 | 0.430 |
Why?
|
| Neurons | 2 | 2014 | 1546 | 0.430 |
Why?
|
| Lipopolysaccharides | 3 | 2016 | 286 | 0.430 |
Why?
|
| Drug Therapy | 1 | 2012 | 70 | 0.430 |
Why?
|
| Neuronal Plasticity | 1 | 2014 | 187 | 0.430 |
Why?
|
| Cyclic AMP | 3 | 2014 | 273 | 0.420 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2014 | 199 | 0.410 |
Why?
|
| Signal Transduction | 9 | 2017 | 3241 | 0.400 |
Why?
|
| MicroRNAs | 2 | 2014 | 534 | 0.400 |
Why?
|
| Energy Metabolism | 3 | 2017 | 271 | 0.400 |
Why?
|
| Lung | 3 | 2014 | 1170 | 0.380 |
Why?
|
| Inflammation | 3 | 2016 | 920 | 0.380 |
Why?
|
| Pulmonary Artery | 3 | 2016 | 305 | 0.330 |
Why?
|
| Up-Regulation | 1 | 2011 | 712 | 0.330 |
Why?
|
| Acute-Phase Proteins | 1 | 2008 | 37 | 0.320 |
Why?
|
| Oxidation-Reduction | 4 | 2017 | 373 | 0.310 |
Why?
|
| Carrier Proteins | 2 | 2008 | 673 | 0.310 |
Why?
|
| Myocardial Contraction | 1 | 2008 | 244 | 0.310 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2007 | 8 | 0.300 |
Why?
|
| Heparin | 1 | 2008 | 175 | 0.300 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2008 | 196 | 0.300 |
Why?
|
| Cells, Cultured | 8 | 2016 | 2818 | 0.290 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2007 | 87 | 0.290 |
Why?
|
| Immunologic Factors | 1 | 2008 | 170 | 0.290 |
Why?
|
| Heart | 1 | 2009 | 539 | 0.290 |
Why?
|
| Algorithms | 1 | 2014 | 1830 | 0.280 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2016 | 81 | 0.270 |
Why?
|
| Membrane Glycoproteins | 1 | 2008 | 428 | 0.270 |
Why?
|
| Animals | 12 | 2017 | 26581 | 0.260 |
Why?
|
| Thrombin | 2 | 2014 | 61 | 0.250 |
Why?
|
| RNA, Small Interfering | 4 | 2014 | 547 | 0.250 |
Why?
|
| Inflammation Mediators | 3 | 2016 | 154 | 0.220 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2012 | 1961 | 0.220 |
Why?
|
| Cell Line | 3 | 2014 | 2468 | 0.220 |
Why?
|
| Endothelium, Vascular | 3 | 2016 | 435 | 0.210 |
Why?
|
| Calsequestrin | 2 | 2012 | 2 | 0.200 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 2 | 2013 | 9 | 0.190 |
Why?
|
| Gene Transfer Techniques | 2 | 2012 | 152 | 0.190 |
Why?
|
| Primary Health Care | 2 | 2014 | 339 | 0.180 |
Why?
|
| Phosphocreatine | 2 | 2009 | 14 | 0.180 |
Why?
|
| Mitochondria, Heart | 2 | 2009 | 50 | 0.170 |
Why?
|
| Animals, Newborn | 2 | 2012 | 510 | 0.170 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 2 | 2016 | 16 | 0.160 |
Why?
|
| Adenosine Triphosphate | 2 | 2009 | 314 | 0.160 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2009 | 318 | 0.160 |
Why?
|
| Cardiac Catheterization | 2 | 2012 | 291 | 0.160 |
Why?
|
| Phosphorylation | 3 | 2016 | 1106 | 0.160 |
Why?
|
| Male | 8 | 2017 | 40956 | 0.150 |
Why?
|
| Phospholipases A2 | 1 | 2016 | 44 | 0.140 |
Why?
|
| Liver | 2 | 2016 | 1229 | 0.140 |
Why?
|
| Ventilator-Induced Lung Injury | 1 | 2016 | 31 | 0.140 |
Why?
|
| Gene Expression | 2 | 2014 | 1284 | 0.140 |
Why?
|
| Duodenum | 1 | 2016 | 100 | 0.140 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 196 | 0.140 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2016 | 71 | 0.130 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2016 | 77 | 0.130 |
Why?
|
| Isolated Heart Preparation | 1 | 2014 | 1 | 0.130 |
Why?
|
| Time Factors | 3 | 2008 | 5209 | 0.130 |
Why?
|
| Carbenoxolone | 1 | 2014 | 5 | 0.130 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2014 | 10 | 0.130 |
Why?
|
| Mice, Inbred ICR | 1 | 2014 | 70 | 0.130 |
Why?
|
| Metabolic Clearance Rate | 1 | 2014 | 121 | 0.130 |
Why?
|
| Cortactin | 1 | 2014 | 11 | 0.130 |
Why?
|
| Myosin Light Chains | 1 | 2014 | 29 | 0.130 |
Why?
|
| Intracellular Space | 1 | 2014 | 38 | 0.130 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2014 | 18 | 0.120 |
Why?
|
| Insulin Resistance | 1 | 2017 | 377 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2014 | 68 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2014 | 74 | 0.120 |
Why?
|
| Humans | 15 | 2016 | 86601 | 0.120 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2014 | 84 | 0.120 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2014 | 54 | 0.120 |
Why?
|
| Paxillin | 1 | 2014 | 59 | 0.120 |
Why?
|
| Microtubules | 1 | 2014 | 119 | 0.120 |
Why?
|
| HEK293 Cells | 2 | 2013 | 615 | 0.120 |
Why?
|
| Muscle, Skeletal | 2 | 2008 | 449 | 0.120 |
Why?
|
| Gap Junctions | 1 | 2014 | 142 | 0.120 |
Why?
|
| Diabetic Retinopathy | 1 | 2014 | 87 | 0.110 |
Why?
|
| Interleukin-8 | 2 | 2016 | 86 | 0.110 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2014 | 176 | 0.110 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2012 | 5 | 0.110 |
Why?
|
| Models, Biological | 2 | 2011 | 1749 | 0.110 |
Why?
|
| Myocardial Reperfusion | 1 | 2012 | 27 | 0.110 |
Why?
|
| Drug Administration Routes | 1 | 2012 | 19 | 0.110 |
Why?
|
| Biotransformation | 1 | 2012 | 50 | 0.110 |
Why?
|
| Drug Dosage Calculations | 1 | 2012 | 16 | 0.110 |
Why?
|
| Pharmacokinetics | 1 | 2012 | 12 | 0.110 |
Why?
|
| Actin Cytoskeleton | 1 | 2014 | 192 | 0.110 |
Why?
|
| Immunoprecipitation | 2 | 2016 | 134 | 0.110 |
Why?
|
| Retina | 1 | 2014 | 213 | 0.110 |
Why?
|
| Physicians, Primary Care | 1 | 2014 | 104 | 0.110 |
Why?
|
| Carbazoles | 1 | 2012 | 51 | 0.110 |
Why?
|
| DNA, Complementary | 1 | 2012 | 393 | 0.110 |
Why?
|
| Drug Monitoring | 1 | 2012 | 118 | 0.100 |
Why?
|
| RNA Interference | 1 | 2013 | 369 | 0.100 |
Why?
|
| Prefrontal Cortex | 1 | 2013 | 129 | 0.100 |
Why?
|
| Chronic Disease | 1 | 2014 | 970 | 0.100 |
Why?
|
| NF-kappa B | 1 | 2014 | 444 | 0.100 |
Why?
|
| Transfection | 1 | 2012 | 896 | 0.100 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 378 | 0.090 |
Why?
|
| Gene Silencing | 1 | 2011 | 172 | 0.090 |
Why?
|
| Myocytes, Cardiac | 1 | 2012 | 275 | 0.090 |
Why?
|
| Palmitates | 1 | 2009 | 18 | 0.090 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 1990 | 0.090 |
Why?
|
| Myocardial Stunning | 1 | 2009 | 12 | 0.090 |
Why?
|
| Neutrophils | 1 | 2011 | 307 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2016 | 683 | 0.090 |
Why?
|
| Transcription, Genetic | 2 | 2011 | 1135 | 0.090 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2009 | 57 | 0.090 |
Why?
|
| Depression | 1 | 2013 | 473 | 0.090 |
Why?
|
| Mitochondria | 1 | 2012 | 535 | 0.090 |
Why?
|
| Citric Acid Cycle | 1 | 2008 | 21 | 0.080 |
Why?
|
| Isoproterenol | 1 | 2008 | 59 | 0.080 |
Why?
|
| Palmitic Acid | 1 | 2008 | 26 | 0.080 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2008 | 72 | 0.080 |
Why?
|
| Culture Media, Serum-Free | 1 | 2008 | 20 | 0.080 |
Why?
|
| Calcium-Binding Proteins | 1 | 2008 | 115 | 0.080 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2008 | 29 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2012 | 589 | 0.080 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 639 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 2705 | 0.080 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 78 | 0.080 |
Why?
|
| In Vitro Techniques | 1 | 2009 | 989 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 937 | 0.080 |
Why?
|
| Radioimmunoassay | 1 | 2007 | 155 | 0.080 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2007 | 78 | 0.070 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2007 | 268 | 0.070 |
Why?
|
| Kinetics | 1 | 2009 | 1513 | 0.070 |
Why?
|
| RNA, Messenger | 1 | 2012 | 1981 | 0.070 |
Why?
|
| Interleukin-6 | 1 | 2008 | 256 | 0.070 |
Why?
|
| Malaria, Falciparum | 1 | 2006 | 12 | 0.070 |
Why?
|
| von Willebrand Factor | 1 | 2006 | 37 | 0.070 |
Why?
|
| Ultrasonography | 1 | 2008 | 695 | 0.070 |
Why?
|
| Lac Operon | 1 | 2005 | 46 | 0.070 |
Why?
|
| Pregnancy | 1 | 2012 | 2893 | 0.070 |
Why?
|
| Hemodynamics | 1 | 2008 | 710 | 0.060 |
Why?
|
| Transgenes | 1 | 2005 | 180 | 0.060 |
Why?
|
| Perfusion | 1 | 2005 | 203 | 0.060 |
Why?
|
| Blotting, Western | 2 | 2016 | 782 | 0.060 |
Why?
|
| Cerebral Cortex | 1 | 2007 | 584 | 0.060 |
Why?
|
| Heart Diseases | 1 | 2005 | 290 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2010 | 1565 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 2232 | 0.050 |
Why?
|
| Mice | 2 | 2013 | 11352 | 0.050 |
Why?
|
| Brain | 1 | 2011 | 2216 | 0.050 |
Why?
|
| Cell Adhesion | 2 | 2016 | 420 | 0.050 |
Why?
|
| Adipose Tissue, White | 1 | 2017 | 18 | 0.040 |
Why?
|
| Adipose Tissue, Brown | 1 | 2017 | 80 | 0.040 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2016 | 56 | 0.040 |
Why?
|
| Adherens Junctions | 1 | 2016 | 34 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2016 | 248 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2016 | 407 | 0.030 |
Why?
|
| Hemostatics | 1 | 2014 | 56 | 0.030 |
Why?
|
| Respiration, Artificial | 1 | 2016 | 334 | 0.030 |
Why?
|
| Phosphodiesterase 4 Inhibitors | 1 | 2013 | 3 | 0.030 |
Why?
|
| Maze Learning | 1 | 2013 | 28 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 280 | 0.030 |
Why?
|
| Lentivirus | 1 | 2013 | 36 | 0.030 |
Why?
|
| Antidepressive Agents | 1 | 2013 | 106 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 273 | 0.030 |
Why?
|
| Vomiting | 1 | 2013 | 193 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 3092 | 0.020 |
Why?
|
| Obesity | 1 | 2017 | 963 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2013 | 373 | 0.020 |
Why?
|
| Cattle | 1 | 2010 | 376 | 0.020 |
Why?
|
| Female | 1 | 2012 | 44507 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2010 | 429 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2010 | 403 | 0.020 |
Why?
|
| Malaria, Cerebral | 1 | 2006 | 4 | 0.020 |
Why?
|
| ABO Blood-Group System | 1 | 2006 | 62 | 0.020 |
Why?
|
| Blood Platelets | 1 | 2006 | 149 | 0.020 |
Why?
|
| Protein Precursors | 1 | 2006 | 143 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2006 | 190 | 0.020 |
Why?
|
| Erythrocytes | 1 | 2006 | 255 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 1920 | 0.010 |
Why?
|
| Infant | 1 | 2006 | 3045 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2006 | 3611 | 0.010 |
Why?
|
| Child | 1 | 2006 | 6926 | 0.010 |
Why?
|